ACUTE AORTIC DISSECTION IN A POSTMENOPAUSAL FEMALE IN THE SETTING OF PARENTERAL TESTOSTERONE, ESTRADIOL, AND PROGESTERONE THERAPY.

Objective: The FDA has not approved the use of testosterone in women. However, parenteral testosterone is being used off-label in free standing clinics throughout America. The recent multi-ethnic study of atherosclerosis (MESA) population study showed that postmenopausal women with a higher testosterone/estradiol ratio had a higher incident of cardiovascular disease.